Update on clinical aspects and treatment of selected vitamin-responsive disorders II (riboflavin and CoQ 10)
- PMID: 22231380
- DOI: 10.1007/s10545-011-9434-1
Update on clinical aspects and treatment of selected vitamin-responsive disorders II (riboflavin and CoQ 10)
Abstract
Riboflavin and ubiquinone (Coenzyme Q(10), CoQ(10)) deficiencies are heterogeneous groups of autosomal recessive conditions affecting both children and adults. Riboflavin (vitamin B(2))-derived cofactors are essential for the function of numerous dehydrogenases. Genetic defects of the riboflavin transport have been detected in Brown-Vialetto-Van Laere and Fazio-Londe syndromes (C20orf54), and haploinsufficiency of GPR172B has been proposed in one patient to cause persistent riboflavin deficiency. Mutations in the electron tranferring fravoprotein genes (ETFA/ETFB) and its dehydrogenase (ETFDH) are causative for multiple acyl-CoA dehydrogenase deficiency. Mutations in ACAD9, encoding the acyl-CoA dehydrogenase 9 protein were recently reported in mitochondrial disease with respiratory chain complex I deficiency. All these conditions may respond to riboflavin therapy. CoQ(10) is a lipid-soluble component of the cell membranes, where it functions as a mobile electron and proton carrier, but also participates in other cellular processes as a potent antioxidant, and by influencing pyrimidine metabolism. The increasing number of molecular defects in enzymes of the CoQ(10) biosynthetic pathways (PDSS1, PDSS2, COQ2, COQ6, COQ9, CABC1/ADCK3) underlies the importance of these conditions. The clinical heterogeneity may reflect blocks at different levels in the complex biosynthetic pathway. Despite the identification of several primary CoQ(10) deficiency genes, the number of reported patients is still low, and no true genotype-phenotype correlations are known which makes the genetic diagnosis still difficult. Additionally to primary CoQ(10) deficiencies, where the mutation impairs a protein directly involved in CoQ(10) biosynthesis, we can differentiate secondary deficiencies. CoQ(10) supplementation may be beneficial in both primary and secondary deficiencies and therefore the early recognition of these diseases is of utmost importance.
Similar articles
-
Genetic bases and clinical manifestations of coenzyme Q10 (CoQ 10) deficiency.J Inherit Metab Dis. 2015 Jan;38(1):145-56. doi: 10.1007/s10545-014-9749-9. Epub 2014 Aug 5. J Inherit Metab Dis. 2015. PMID: 25091424 Review.
-
Riboflavin in Neurological Diseases: A Narrative Review.Clin Drug Investig. 2021 Jun;41(6):513-527. doi: 10.1007/s40261-021-01038-1. Epub 2021 Apr 22. Clin Drug Investig. 2021. PMID: 33886098 Review.
-
Molecular and Clinical Investigations on Portuguese Patients with Multiple acyl-CoA Dehydrogenase Deficiency.Curr Mol Med. 2019;19(7):487-493. doi: 10.2174/1566524019666190507114748. Curr Mol Med. 2019. PMID: 31418342
-
Novel mutations in ETFDH gene in Chinese patients with riboflavin-responsive multiple acyl-CoA dehydrogenase deficiency.Clin Chim Acta. 2009 Jun 27;404(2):95-9. doi: 10.1016/j.cca.2009.02.015. Epub 2009 Mar 3. Clin Chim Acta. 2009. PMID: 19265687
-
Mitochondrial energetic impairment in a patient with late-onset glutaric acidemia Type 2.Am J Med Genet A. 2020 Oct;182(10):2426-2431. doi: 10.1002/ajmg.a.61786. Epub 2020 Aug 17. Am J Med Genet A. 2020. PMID: 32804429 Free PMC article.
Cited by
-
Clinical Diagnosis and Treatment of Leigh Syndrome Based on SURF1: Genotype and Phenotype.Antioxidants (Basel). 2021 Dec 5;10(12):1950. doi: 10.3390/antiox10121950. Antioxidants (Basel). 2021. PMID: 34943053 Free PMC article. Review.
-
Diagnosis and management of progressive ataxia in adults.Pract Neurol. 2019 Jun;19(3):196-207. doi: 10.1136/practneurol-2018-002096. Epub 2019 May 2. Pract Neurol. 2019. PMID: 31048364 Free PMC article. Review.
-
Combined isobutyryl-CoA and multiple acyl-CoA dehydrogenase deficiency in a boy with altered riboflavin homeostasis.JIMD Rep. 2022 May 7;63(4):276-291. doi: 10.1002/jmd2.12292. eCollection 2022 Jul. JIMD Rep. 2022. PMID: 35822092 Free PMC article.
-
A regulatory role of NAD redox status on flavin cofactor homeostasis in S. cerevisiae mitochondria.Oxid Med Cell Longev. 2013;2013:612784. doi: 10.1155/2013/612784. Epub 2013 Sep 1. Oxid Med Cell Longev. 2013. PMID: 24078860 Free PMC article.
-
Alteration of ROS homeostasis and decreased lifespan in S. cerevisiae elicited by deletion of the mitochondrial translocator FLX1.Biomed Res Int. 2014;2014:101286. doi: 10.1155/2014/101286. Epub 2014 May 8. Biomed Res Int. 2014. PMID: 24895546 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous